Adjuvant trastuzumab in early HER2-positive breast cancer: Journeying towards the optimal duration of therapy in South Africa - Wiseman, R J; Riddin, J; Jugathpal, J; Parrish, A J; Ruff, P; Blockman, M (S Afr Med J, 2020)